Assist. Prof. Dr. Hagos Tesfay Medhin, Addis Ababa University, Ethiopia.
Hagos Tesfay Medhin is a distinguished expert in chemistry and nuclear medicine, holding a Ph.D. in Analytical Chemistry from Addis Ababa University (2015), where he achieved an impressive CGPA of 4.00. With over three decades of experience, he has made significant contributions in teaching, research, and healthcare. His expertise spans analytical and radiochemistry, focusing on developing polymer/dye-based radiochromic dosimeters for medical and environmental applications. Currently, he serves at the Nuclear Medicine Unit, Addis Ababa University, excelling in radiopharmaceutical preparation and education. A dedicated scholar, he has undertaken various international fellowships, enhancing his impact in nuclear medicine. 
Professional Profile:
🎓Education
- Elementary School: Queen Sheba Primary School (Adwa), 1973–1978
- Junior Secondary: Queen Sheba Secondary School (Adwa), 1979–1980
- Secondary School: Queen Sheba Secondary School (Adwa), 1981–1984
- B.Sc.: Chemistry, Addis Ababa University, 1984–1988
- M.Sc.: Chemistry, Addis Ababa University, 1995–1997
- Ph.D.: Analytical Chemistry, Addis Ababa University, 2010–2015 (CGPA: 4.00, Excellent)
🏢Experience
- Chemistry Teacher, Merti Comprehensive Secondary School (1988–1991)
- Principal and Teacher, Tilahun Gizaw Secondary School (1992–1994)
- Lecturer and Registrar, Abbiyi Addi College of Teacher Education (1997–1999)
- Lecturer, Mekelle University (2001–2002)
- Lecturer and Assistant Dean, Mekelle Institute of Technology (2002–2003)
- Academic Dean, Atlas College of Health Sciences (2004–2007)
- Lecturer and Radiopharmaceutical Specialist, Addis Ababa University, Nuclear Medicine Unit (2007–present)
Suitability for the Award
Assist. Prof. Dr. Hagos Tesfay Medhin is an exceptional candidate for the Best Faculty Award, with an extensive academic background and a wealth of professional experience in chemistry, radiopharmacy, and nuclear medicine. His contributions span over three decades, showcasing his commitment to education, research, and the development of the field.
Professional Development
Hagos Tesfay Medhin has honed his expertise through diverse training and fellowships. He trained in radiopharmacy at Stellenbosch University, South Africa (2009), and attended a regional IAEA course in Uganda (2011). His research fellowship at Săo Paulo State University, Brazil (2013), focused on polymer-based dosimeters, followed by a stint at the National Cancer Institute in Italy (2017) on natural dye-based dosimeters. Most recently, he undertook Erasmus+ Mobility training at the University of Pisa (2023), enhancing his skills in radiopharmaceuticals for SPECT and PET imaging. His dedication to continuous learning ensures global contributions to nuclear medicine. 
🏅Awards and Honors
Ph.D. with Excellence: Addis Ababa University (CGPA: 4.00), 2015
Certificate of Completion: Nuclear Medicine Training, University of Pisa, 2023
Recognition: Advanced Materials Characterization Workshop, University of Illinois, 2024- Fellowship Training: Stellenbosch University, Săo Paulo State University, and Naples National Cancer Institute.
🔬Research Focus
Hagos Tesfay Medhin’s research emphasizes nuclear medicine and radiochemistry, particularly the development of polymer/dye-based radiochromic dosimeters. These dosimeters find applications in radiation therapy and environmental monitoring. His innovative approaches have centered on optimizing dosimeter sensitivity and accuracy for medical diagnostics and environmental safety. Additionally, he contributes to radiopharmacy, improving radiopharmaceutical quality for PET and SPECT imaging. His interdisciplinary work bridges chemistry and healthcare, fostering advancements in radiopharmaceutical applications and analytical methods. His research aligns with global priorities in safe and effective nuclear medicine practices. 
Publication Top Notes:
-
Proteomic Analysis of Biomarkers Predicting Treatment Response in Patients with Head and Neck Cancers (Published: 2019, Cited by: 75) 
